SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Y. Li, H. Salmasian, S. Vilar, H. Chase, C. Friedman, Y. Wei, A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records, Journal of the American Medical Informatics Association, 2014, 21, 2, 308

    CrossRef

  2. 2
    Marianthi Markatou, Robert Ball, A pattern discovery framework for adverse event evaluation and inference in spontaneous reporting systems, Statistical Analysis and Data Mining: The ASA Data Science Journal, 2014, 7, 5
  3. 3
    SriJyothsna Yeleswarapu, Aditya Rao, Thomas Joseph, Vangala Saipradeep, Rajgopal Srinivasan, A pipeline to extract drug-adverse event pairs from multiple data sources, BMC Medical Informatics and Decision Making, 2014, 14, 1, 13

    CrossRef

  4. 4
    David Madigan, Paul E. Stang, Jesse A. Berlin, Martijn Schuemie, J. Marc Overhage, Marc A. Suchard, Bill Dumouchel, Abraham G. Hartzema, Patrick B. Ryan, A Systematic Statistical Approach to Evaluating Evidence from Observational Studies, Annual Review of Statistics and Its Application, 2014, 1, 1, 11

    CrossRef

  5. 5
    Tyler H. McCormick, Rebecca Ferrell, Alan F. Karr, Patrick B. Ryan, Big data, big results: Knowledge discovery in output from large-scale analytics, Statistical Analysis and Data Mining: The ASA Data Science Journal, 2014, 7, 5
  6. 6
    Richard D. Boyce, Patrick B. Ryan, G. Niklas Norén, Martijn J. Schuemie, Christian Reich, Jon Duke, Nicholas P. Tatonetti, Gianluca Trifirò, Rave Harpaz, J. Marc Overhage, Abraham G. Hartzema, Mark Khayter, Erica A. Voss, Christophe G. Lambert, Vojtech Huser, Michel Dumontier, Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest, Drug Safety, 2014, 37, 8, 557

    CrossRef

  7. 7
    Carlos Bell, Aloka Chakravarty, Susan Gruber, Susan R. Heckbert, Mark Levenson, David Martin, Jennifer C. Nelson, Simone Pinheiro, Bruce M. Psaty, Christian G. Reich, Sebastian Schneeweiss, Azadeh Shoaibi, Sengwee Toh, Alexander M. Walker, Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems, Pharmacoepidemiology and Drug Safety, 2014, 23, 10
  8. 8
    Victor M. Castro, W. Kay Apperson, Vivian S. Gainer, Ashwin N. Ananthakrishnan, Alyssa P. Goodson, Taowei D. Wang, Christopher D. Herrick, Shawn N. Murphy, Evaluation of matched control algorithms in EHR-based phenotyping studies: A case study of inflammatory bowel disease comorbidities, Journal of Biomedical Informatics, 2014,

    CrossRef

  9. 9
    Richard A. Hansen, Michael D. Gray, Brent I. Fox, Joshua C. Hollingsworth, Juan Gao, Michael L. Hollingsworth, David Mark Carpenter, Expert panel assessment of acute liver injury identification in observational data, Research in Social and Administrative Pharmacy, 2014, 10, 1, 156

    CrossRef

  10. 10
    Richard A. Hansen, Peng Zeng, Patrick Ryan, Juan Gao, Kalyani Sonawane, Benjamin Teeter, Kimberly Westrich, Robert W. Dubois, Exploration of heterogeneity in distributed research network drug safety analyses, Research Synthesis Methods, 2014, 5, 3
  11. 11
    Jennifer C. Nelson, Susan M. Shortreed, Onchee Yu, Do Peterson, Roger Baxter, Bruce Fireman, Ned Lewis, Dave McClure, Eric Weintraub, Stan Xu, Lisa A. Jackson, Integrating database knowledge and epidemiological design to improve the implementation of data mining methods that evaluate vaccine safety in large healthcare databases, Statistical Analysis and Data Mining: The ASA Data Science Journal, 2014, 7, 5
  12. 12
    Gerald J. Dal Pan, Ongoing Challenges in Pharmacovigilance, Drug Safety, 2014, 37, 1, 1

    CrossRef

  13. 13
    Carmen Ferrajolo, Annalisa Capuano, Gianluca Trifirò, Ugo Moretti, Francesco Rossi, Carmela Santuccio, Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 – 2012, Expert Opinion on Drug Safety, 2014, 13, S1, 9

    CrossRef

  14. 14
    S. Doan, K.-W. Lin, M. Conway, L. Ohno-Machado, A. Hsieh, S. F. Feupe, A. Garland, M. K. Ross, X. Jiang, S. Farzaneh, R. Walker, N. Alipanah, J. Zhang, H. Xu, H.-E. Kim, PhenDisco: phenotype discovery system for the database of genotypes and phenotypes, Journal of the American Medical Informatics Association, 2014, 21, 1, 31

    CrossRef

  15. 15
    J. P. A. Ioannidis, Y. Zhou, C. Q. Chang, S. D. Schully, M. J. Khoury, A. N. Freedman, Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses, Annals of Oncology, 2014, 25, 1, 16

    CrossRef

  16. 16
    Cynthia J Girman, Douglas Faries, Patrick Ryan, Matt Rotelli, Mark Belger, Bruce Binkowitz, Robert O’Neill, Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research, Journal of Comparative Effectiveness Research, 2014, 3, 3, 259

    CrossRef

  17. 17
    L. Ohno-Machado, Z. Agha, D. S. Bell, L. Dahm, M. E. Day, J. N. Doctor, D. Gabriel, M. K. Kahlon, K. K. Kim, M. Hogarth, M. E. Matheny, D. Meeker, J. R. Nebeker, F. Resnic, D. Khodyakov, L. Armstead, T. Nagler, S. Morley, N. Anderson, D. Cooper, D. Phillips, D. Heber, Z. Li, M. K. Ong, A. Patel, M. Zachariah, J. C. Burns, L. B. Daniels, S. Doan, C. Farcas, R. Germann-Kurtz, X. Jiang, H.-e. Kim, P. Paul, H. Taras, A. Tremoulet, S. Wang, W. Zhu, D. Berman, A. Rizk-Jackson, M. D'Arcy, C. Kesselman, T. Knight, L. Pearlman, P. Heidenreich, D. Rifkin, C. Stepnowsky, T. Zamora, S. L. DuVall, L. J. Frey, J. Scehnet, B. C. Sauer, J. C. Facelli, R. K. Gouripeddi, J. Denton, F. FitzHenry, J. Fly, V. Messina, F. Minter, L. Nookala, H. Sullivan, T. Speroff, D. Westerman, pSCANNER: patient-centered Scalable National Network for Effectiveness Research, Journal of the American Medical Informatics Association, 2014, 21, 4, 621

    CrossRef

  18. 18
    Jenna M. Reps, Jonathan M. Garibaldi, Uwe Aickelin, Daniele Soria, Jack E. Gibson, Richard B. Hubbard, Signalling Paediatric Side Effects using an Ensemble of Simple Study Designs, Drug Safety, 2014, 37, 3, 163

    CrossRef

  19. 19
    S Vilar, P B Ryan, D Madigan, P E Stang, M J Schuemie, C Friedman, N P Tatonetti, G Hripcsak, Similarity-Based Modeling Applied to Signal Detection in Pharmacovigilance, CPT Pharmacometrics Syst. Pharmacol., 2014, 3, 9, e137

    CrossRef

  20. 20
    R W White, R Harpaz, N H Shah, W DuMouchel, E Horvitz, Toward Enhanced Pharmacovigilance Using Patient-Generated Data on the Internet, Clinical Pharmacology & Therapeutics, 2014, 96, 2, 239

    CrossRef

  21. 21
    Patrick B. Ryan, Paul E. Stang, J. Marc Overhage, Marc A. Suchard, Abraham G. Hartzema, William DuMouchel, Christian G. Reich, Martijn J. Schuemie, David Madigan, A Comparison of the Empirical Performance of Methods for a Risk Identification System, Drug Safety, 2013, 36, S1, 143

    CrossRef

  22. 22
    Jenna Marie Reps, Jonathan M. Garibaldi, Uwe Aickelin, Daniele Soria, Jack Gibson, Richard Hubbard, Comparison of algorithms that detect drug side effects using electronic healthcare databases, Soft Computing, 2013, 17, 12, 2381

    CrossRef

  23. 23
    Patrick B. Ryan, Martijn J. Schuemie, Emily Welebob, Jon Duke, Sarah Valentine, Abraham G. Hartzema, Defining a Reference Set to Support Methodological Research in Drug Safety, Drug Safety, 2013, 36, S1, 33

    CrossRef

  24. 24
    J. Marc Overhage, Patrick B. Ryan, Martijn J. Schuemie, Paul E. Stang, Desideratum for Evidence Based Epidemiology, Drug Safety, 2013, 36, S1, 5

    CrossRef

  25. 25
    Jeffrey Brown, Kenneth Petronis, Andrew Bate, Fang Zhang, Inna Dashevsky, Martin Kulldorff, Taliser Avery, Robert Davis, K. Chan, Susan Andrade, Denise Boudreau, Margaret Gunter, Lisa Herrinton, Pamala Pawloski, Marsha Raebel, Douglas Roblin, David Smith, Robert Reynolds, Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic, Pharmaceutics, 2013, 5, 1, 179

    CrossRef

  26. 26
    Patrick B. Ryan, Martijn J. Schuemie, Susan Gruber, Ivan Zorych, David Madigan, Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System, Drug Safety, 2013, 36, S1, 59

    CrossRef

  27. 27
    G. Niklas Norén, Tomas Bergvall, Patrick B. Ryan, Kristina Juhlin, Martijn J. Schuemie, David Madigan, Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System, Drug Safety, 2013, 36, S1, 107

    CrossRef

  28. 28
    Patrick B. Ryan, Martijn J. Schuemie, Evaluating Performance of Risk Identification Methods Through a Large-Scale Simulation of Observational Data, Drug Safety, 2013, 36, S1, 171

    CrossRef

  29. 29
    D. Madigan, P. B. Ryan, M. Schuemie, P. E. Stang, J. M. Overhage, A. G. Hartzema, M. A. Suchard, W. DuMouchel, J. A. Berlin, Evaluating the Impact of Database Heterogeneity on Observational Study Results, American Journal of Epidemiology, 2013, 178, 4, 645

    CrossRef

  30. 30
    P B Ryan, D Madigan, P E Stang, M J Schuemie, G Hripcsak, Medication-Wide Association Studies, CPT: Pharmacometrics & Systems Pharmacology, 2013, 2, 9, e76

    CrossRef

  31. 31
    Anjan K. Banerjee, Sally Okun, I. Ralph Edwards, Paul Wicks, Meredith Y. Smith, Stephen J. Mayall, Bruno Flamion, Charles Cleeland, Ethan Basch, Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance, Drug Safety, 2013, 36, 12, 1129

    CrossRef

  32. 32
    R Harpaz, W DuMouchel, P LePendu, A Bauer-Mehren, P Ryan, N H Shah, Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System, Clinical Pharmacology & Therapeutics, 2013, 93, 6, 539

    CrossRef

  33. 33
    P. M. Fleischut, M. Mazumdar, S. G. Memtsoudis, Perioperative database research: possibilities and pitfalls, British Journal of Anaesthesia, 2013, 111, 4, 532

    CrossRef

  34. 34
    P LePendu, S V Iyer, A Bauer-Mehren, R Harpaz, J M Mortensen, T Podchiyska, T A Ferris, N H Shah, Pharmacovigilance Using Clinical Notes, Clinical Pharmacology & Therapeutics, 2013, 93, 6, 547

    CrossRef

  35. 35
    Martijn J. Schuemie, Rosa Gini, Preciosa M. Coloma, Huub Straatman, Ron M. C. Herings, Lars Pedersen, Francesco Innocenti, Giampiero Mazzaglia, Gino Picelli, Johan van der Lei, Miriam C. J. M. Sturkenboom, Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases, Drug Safety, 2013, 36, S1, 159

    CrossRef

  36. 36
    Patrick B. Ryan, David Madigan, Paul E. Stang, J. Marc Overhage, Judith A. Racoosin, Abraham G. Hartzema, Response to Comment on ‘Empirical assessment of methods for risk identification in healthcare data’, Statistics in Medicine, 2013, 32, 6
  37. 37
    Xiaochun Li, Siu Hui, Patrick Ryan, Marc Rosenman, Marc Overhage, Statistical visualization for assessing performance of methods for safety surveillance using electronic databases, Pharmacoepidemiology and Drug Safety, 2013, 22, 5
  38. 38
    Christian G. Reich, Patrick B. Ryan, Marc A. Suchard, The Impact of Drug and Outcome Prevalence on the Feasibility and Performance of Analytical Methods for a Risk Identification and Analysis System, Drug Safety, 2013, 36, S1, 195

    CrossRef

  39. 39
    Paul E. Stang, Patrick B. Ryan, J. Marc Overhage, Martijn J. Schuemie, Abraham G. Hartzema, Emily Welebob, Variation in Choice of Study Design: Findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) Survey, Drug Safety, 2013, 36, S1, 15

    CrossRef

  40. 40
    Marc Suling, Iris Pigeot, Signal Detection and Monitoring Based on Longitudinal Healthcare Data, Pharmaceutics, 2012, 4, 4, 607

    CrossRef

  41. 41
    Andrew Bate, Antoine Pariente, Manfred Hauben, Bernard Bégaud, Quantitative Signal Detection and Analysis in Pharmacovigilance,